Rtw Investments as of March 31, 2024
Portfolio Holdings for Rtw Investments
Rtw Investments holds 69 positions in its portfolio as reported in the March 2024 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Rocket Pharmaceuticals (RCKT) | 7.0 | $477M | 18M | 26.94 | |
Immunocore Hldgs Ads (IMCR) | 5.8 | $391M | 6.0M | 65.00 | |
Axsome Therapeutics (AXSM) | 5.3 | $359M | 4.5M | 79.80 | |
Ultragenyx Pharmaceutical (RARE) | 4.9 | $331M | 7.1M | 46.69 | |
Bruker Corporation (BRKR) | 4.6 | $314M | 3.3M | 93.94 | |
Argenx Se Sponsored Adr (ARGX) | 3.9 | $263M | 667k | 393.72 | |
ACADIA Pharmaceuticals (ACAD) | 3.8 | $256M | 14M | 18.49 | |
Natera (NTRA) | 3.5 | $237M | 2.6M | 91.46 | |
Ptc Therapeutics I (PTCT) | 3.2 | $216M | 7.4M | 29.09 | |
Masimo Corporation (MASI) | 3.2 | $215M | 1.5M | 146.85 | |
Avidity Biosciences Ord (RNA) | 3.0 | $203M | 8.0M | 25.52 | |
Merus N V (MRUS) | 2.7 | $185M | 4.1M | 45.03 | |
Cytokinetics Com New (CYTK) | 2.6 | $177M | 2.5M | 70.11 | |
Apogee Therapeutics (APGE) | 2.4 | $164M | 2.5M | 66.45 | |
Alkermes SHS (ALKS) | 2.4 | $164M | 6.1M | 27.07 | |
Protagonist Therapeutics (PTGX) | 2.3 | $154M | 5.3M | 28.93 | |
Penumbra (PEN) | 2.2 | $151M | 676k | 223.18 | |
Avadel Pharmaceuticals Sponsored Adr | 2.2 | $149M | 8.8M | 16.89 | |
Akero Therapeutics (AKRO) | 2.0 | $137M | 5.4M | 25.26 | |
Establishment Labs Holdings Ord (ESTA) | 2.0 | $136M | 2.7M | 50.90 | |
Arvinas Ord (ARVN) | 2.0 | $136M | 3.3M | 41.28 | |
Tarsus Pharmaceuticals (TARS) | 1.8 | $119M | 3.3M | 36.35 | |
Stryker Corporation (SYK) | 1.7 | $115M | 321k | 357.87 | |
Madrigal Pharmaceuticals (MDGL) | 1.6 | $106M | 397k | 267.04 | |
Immatics SHS (IMTX) | 1.6 | $105M | 10M | 10.51 | |
Sage Therapeutics (SAGE) | 1.5 | $103M | 5.5M | 18.74 | |
Shockwave Med | 1.4 | $94M | 289k | 325.63 | |
Dyne Therapeutics (DYN) | 1.3 | $88M | 3.1M | 28.39 | |
89bio (ETNB) | 1.3 | $86M | 7.4M | 11.64 | |
Spyre Therapeutics Com New (SYRE) | 1.3 | $85M | 2.2M | 37.93 | |
Vericel (VCEL) | 1.2 | $84M | 1.6M | 52.02 | |
Cargo Therapeutics (CRGX) | 1.2 | $83M | 3.7M | 22.32 | |
RadNet (RDNT) | 1.2 | $83M | 1.7M | 48.66 | |
Thermo Fisher Scientific (TMO) | 0.9 | $64M | 111k | 581.21 | |
10x Genomics Cl A Com (TXG) | 0.9 | $58M | 1.6M | 37.53 | |
Stoke Therapeutics (STOK) | 0.8 | $57M | 4.2M | 13.50 | |
Fulcrum Therapeutics (FULC) | 0.8 | $55M | 5.8M | 9.44 | |
Taysha Gene Therapies Com Shs (TSHA) | 0.8 | $53M | 19M | 2.87 | |
Insmed Com Par $.01 (INSM) | 0.7 | $51M | 1.9M | 27.13 | |
Urogen Pharma (URGN) | 0.7 | $49M | 3.3M | 15.00 | |
Kyverna Therapeutics (KYTX) | 0.7 | $46M | 1.9M | 24.84 | |
Intuitive Surgical Com New (ISRG) | 0.6 | $40M | 99k | 399.09 | |
Neurogene (NGNE) | 0.6 | $39M | 769k | 50.90 | |
Janux Therapeutics (JANX) | 0.6 | $38M | 1.0M | 37.65 | |
Gh Research Ordinary Shares (GHRS) | 0.5 | $36M | 3.3M | 10.66 | |
Health Sciences Acq Corp 2 (OBIO) | 0.4 | $30M | 5.6M | 5.27 | |
Dianthus Therapeutics (DNTH) | 0.3 | $20M | 667k | 30.00 | |
Essa Pharma Com New (EPIX) | 0.3 | $20M | 2.3M | 8.49 | |
Lenz Therapeutics (LENZ) | 0.3 | $19M | 863k | 22.33 | |
Cg Oncology (CGON) | 0.3 | $18M | 414k | 43.90 | |
Tourmaline Bio (TRML) | 0.3 | $17M | 742k | 22.90 | |
Roivant Sciences SHS (ROIV) | 0.2 | $15M | 1.5M | 10.54 | |
Miragen Therapeutics (VRDN) | 0.2 | $11M | 606k | 17.51 | |
Adicet Bio (ACET) | 0.1 | $9.7M | 4.1M | 2.35 | |
Regenxbio Inc equity us cm (RGNX) | 0.1 | $7.4M | 350k | 21.07 | |
Acelyrin (SLRN) | 0.1 | $6.6M | 978k | 6.75 | |
EXACT Sciences Corporation (EXAS) | 0.1 | $6.6M | 95k | 69.06 | |
Allurion Technologies Com Shs (ALUR) | 0.1 | $6.1M | 3.5M | 1.75 | |
Immunic (IMUX) | 0.1 | $6.0M | 4.6M | 1.32 | |
Milestone Pharmaceuticals (MIST) | 0.1 | $5.8M | 3.3M | 1.79 | |
Glaukos (GKOS) | 0.1 | $5.5M | 59k | 94.29 | |
Sagimet Biosciences Com Ser A (SGMT) | 0.1 | $5.4M | 999k | 5.42 | |
Larimar Therapeutics (LRMR) | 0.1 | $4.9M | 650k | 7.59 | |
Sab Biotherapeutics Com New (SABS) | 0.1 | $4.2M | 918k | 4.54 | |
Exagen (XGN) | 0.0 | $2.4M | 1.5M | 1.59 | |
Beyond Air (XAIR) | 0.0 | $2.1M | 1.2M | 1.74 | |
Cutera (CUTR) | 0.0 | $2.0M | 1.3M | 1.47 | |
Arya Sciences Acqu Corp Iv Cl A (ARYD) | 0.0 | $1.4M | 128k | 11.23 | |
Rocket Pharmaceuticals *w Exp 09/02/202 (RCKTW) | 0.0 | $105k | 350k | 0.30 |